benchmark
Showing 26 - 50 of 756
Influenza, Influenza Immunization Trial in United States (Influenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant
Completed
- Influenza
- Influenza Immunization
- Influenza Hemagglutinin mRNA vaccine
- Quadrivalent Recombinant Influenza Vaccine
-
Rolling Hills Estates, California
- +19 more
Oct 31, 2023
Lyme Disease Trial in United States (VLA15, Normal Saline)
Recruiting
- Lyme Disease
- VLA15
- Normal Saline
-
Guntersville, Alabama
- +24 more
Jan 19, 2023
Use of Wearable Digital Sensors After mRNA Vaccination in Adults
Recruiting
- Healthy Participants
- Wireless wearable digital devices
-
Hollywood, Florida
- +7 more
Jun 27, 2022
Cytomegalovirus Infection Trial in United States (mRNA-1647, Placebo)
Completed
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Sacramento, California
- +8 more
Jan 11, 2023
SARS-CoV-2 Trial in Australia, Philippines, United States (CV0501 (3 µg), CV0501 (6 µg), CV0501 (12 µg))
Not yet recruiting
- SARS-CoV-2
- CV0501 (3 μg)
- +8 more
-
Sacramento, California
- +19 more
Jul 27, 2022
SARS-CoV-2, Seasonal Influenza, Respiratory Syncytial Virus Trial in United States (mRNA-1273, mRNA-1010, mRNA-1345)
Recruiting
- SARS-CoV-2
- +3 more
- mRNA-1273
- +4 more
-
Hollywood, Florida
- +7 more
May 25, 2022
Respiratory Syncytial Virus Trial in Worldwide (mRNA-1345)
Not yet recruiting
- Respiratory Syncytial Virus
- mRNA-1345
-
Glendale, Arizona
- +47 more
Sep 27, 2023
Zika Virus Trial in Puerto Rico, United States (mRNA-1893, Placebo)
Completed
- Zika Virus
- mRNA-1893
- Placebo
-
Omaha, Nebraska
- +3 more
Apr 20, 2021
Neck Pain, Low Back Pain, Chronic Pain Trial in United States (Pain neuroscience education training)
Completed
- Neck Pain
- +2 more
- Pain neuroscience education training
-
Birmingham, Alabama
- +40 more
Jul 28, 2020
Healthy Volunteers, Pneumococcal Disease Trial in United States (ASP3772, PCV13, PPSV23)
Completed
- Healthy Volunteers
- Pneumococcal Disease
- ASP3772
- +2 more
-
Banning, California
- +25 more
Apr 27, 2022
Healthy Volunteers, Norovirus Trial in Belgium, United States (NoV Vaccine)
Completed
- Healthy Volunteers
- Norovirus
- NoV Vaccine
-
Birmingham, Alabama
- +10 more
Nov 7, 2022
Zika Virus Trial in Puerto Rico, United States (mRNA-1893, Placebo)
Active, not recruiting
- Zika Virus
- mRNA-1893
- Placebo
-
Sioux City, Iowa
- +10 more
Aug 31, 2022
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b5 Bivalent (WT/OMI BA.2), BNT162b2 Bivalent (WT/OMI BA.1))
Recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b5 Bivalent (WT/OMI BA.2)
- BNT162b2 Bivalent (WT/OMI BA.1)
-
Anaheim, California
- +9 more
Aug 8, 2022
Respiratory Syncytial Virus (RSV) Trial in United States (Investigational RSV vaccine MV-012-968 (Dosage 1), Investigational RSV
Recruiting
- Respiratory Syncytial Virus (RSV)
- Investigational RSV vaccine MV-012-968 (Dosage 1)
- +5 more
-
Phoenix, Arizona
- +11 more
Aug 1, 2022
Point-of-Care, SARS-CoV-2 IgG Antibody Test in Fingerstick Whole
Completed
- SARS-Cov-2, Covid19
- POC SARS-Cov-2 IgG Antibody test
-
Colton, California
- +2 more
Jun 15, 2021
Lyme Disease Trial in United States (mRNA-1975, mRNA-1982, Placebo)
Recruiting
- Lyme Disease
- mRNA-1975
- +2 more
-
Milford, Connecticut
- +19 more
Jul 26, 2023
Epstein-Barr Virus Infection Trial in United States (mRNA-1189, Placebo)
Recruiting
- Epstein-Barr Virus Infection
- mRNA-1189
- Placebo
-
Hollywood, Florida
- +15 more
Jul 14, 2022
COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)
Recruiting
- COVID-19
- mRNA-1283.222
- mRNA-1273.222
-
Birmingham, Alabama
- +209 more
Apr 13, 2023
Clostridium Difficile Associated Disease Trial in United States (Clostridium difficile vaccine, )
Completed
- Clostridium Difficile Associated Disease
- Clostridium difficile vaccine
- placebo
-
Mobile, Alabama
- +23 more
Dec 21, 2022
SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
-
Anaheim, California
- +20 more
Nov 30, 2022
Respiratory Tract Infections Trial in United States (Formulation A, Formulation B, Placebo)
Completed
- Respiratory Tract Infections
- Formulation A
- +2 more
-
Mobile, Alabama
- +39 more
Mar 1, 2022